EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema

Kazuya Tsubouchi iD, Yasuaki Kotetsu, Tomotsugu Takano, Hiroaki Ogata, Fumiaki Kiyomi, Katsuyuki Ichiki, Shohei Takata, Yasuhiko Kitasato, Hiroshi Ishii, Kazuhiro Yatera, Kei Yamasaki, Masaki Okamoto und 12 weitere

Respirology · 2026-11 · 31 (11) · 1117-1125

DOI: 10.1002/resp.70285 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Respirology, online erschienen am 08.07.2026. Verfasst von Kazuya Tsubouchi und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Pulmonary Emphysema, Pulmonary Fibrosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, Boehringer Ingelheim, The Ministry of Health, Labour and Welfare (MHLW), Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Combined pulmonary fibrosis and emphysema (CPFE) is characterized by coexisting upper‐zone emphysema and lower‐zone fibrosis, but standardized diagnostic criteria and clinical outcomes remain poorly defined. This study aimed to evaluate survival, acute exacerbation incidence, and disease progression in CPFE patients using international classification criteria with visual assessment of emphysema extent.

Methods

This multicentre prospective cohort study at 29 Japanese hospitals enrolled 1016 patients with idiopathic interstitial pneumonias (IIPs) or chronic obstructive pulmonary disease (COPD) between 2013 and 2016. CPFE was defined as ≥ 5% emphysema determined by visual assessment of CT scans for IIP patients, according to international classification criteria. Patients were followed for 5 years.

Results

Among 528 IIP patients, 92 (17.4%) had CPFE. CPFE patients showed a significantly worse 5‐year survival compared with non‐CPFE IIP patients (51.4% vs. 63.1%, p = 0.026) and COPD patients (51.4% vs. 84.0%, p < 0.001). After adjustment for covariates including IIP subtype, CPFE remained independently associated with increased mortality among IIP patients (HR of 1.85 [95% CI, 1.27–2.69], p < 0.001). CPFE patients also had a significantly higher acute exacerbation rate than did non‐CPFE IIP patients ( p < 0.001). The prognostic impact of CPFE was most pronounced in patients with idiopathic pulmonary fibrosis (IPF), with CPFE/IPF patients showing the worst outcomes.

Conclusion

Visual assessment with a ≥ 5% emphysema threshold effectively identified CPFE patients with a distinct clinical phenotype characterized by poor survival and an increased acute exacerbation incidence. These findings validate international classification criteria and emphasize the need for enhanced surveillance and tailored management strategies for this high‐risk population. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmphysemaPulmonary FibrosisHumansFemaleMaleDisease ProgressionAgedProspective StudiesIncidenceJapanTomography, X-Ray ComputedMiddle AgedPrognosisPulmonary Disease, Chronic Obstructive

Stichwörter der Autor:innen

CPFEacute exacerbationemphysemapulmonary fibrosisvisual assessment

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Clinical Research Support Center Kyushu, Fukuoka, Japan.
  • Kirigaoka Tsuda Hospital, Kitakyushu, Japan.
  • Department of Respiratory Diseases, NHO Fukuokahigashi Medical Center, Koga, Japan.
  • Department of Respiratory Medicine, Japan Community Health Care Organization Kurume General Hospital, Kurume, Japan.
  • Department of Respiratory Medicine, Fukuoka University Chikushi Hospital, Chikushino, Japan.

ORCID-Profile: Kazuya Tsubouchi, Masaki Fujita, Taishi Harada

Förderung

  • The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan
  • Boehringer Ingelheim
  • The Ministry of Health, Labour and Welfare (MHLW), Japan
  • Ministry of Health Mexico

Zitieren

APA

Tsubouchi, K., Kotetsu, Y., Takano, T., Ogata, H., Kiyomi, F., Ichiki, K., Takata, S., Kitasato, Y., Ishii, H., Yatera, K., Yamasaki, K., Okamoto, M., Yoshida, M., Kawasaki, M., Fujita, M., Ogawa, T., Tobino, K., Harada, E., Nakagaki, N., …, & Okamoto, I. (2026). Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema. Respirology, 31(11), 1117-1125. https://doi.org/10.1002/resp.70285

Vancouver

Tsubouchi K, Kotetsu Y, Takano T, Ogata H, Kiyomi F, Ichiki K, et al. Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema. Respirology. 2026;31(11):1117-1125. doi:10.1002/resp.70285

BibTeX
@article{Tsubouchi2026,
  author = {Tsubouchi, Kazuya and Kotetsu, Yasuaki and Takano, Tomotsugu and Ogata, Hiroaki and Kiyomi, Fumiaki and Ichiki, Katsuyuki and Takata, Shohei and Kitasato, Yasuhiko and Ishii, Hiroshi and Yatera, Kazuhiro and Yamasaki, Kei and Okamoto, Masaki and Yoshida, Makoto and Kawasaki, Masayuki and Fujita, Masaki and Ogawa, Tomohiro and Tobino, Kazunori and Harada, Eiji and Nakagaki, Noriaki and Komori, Masashi and Harada, Taishi and Wataya, Hiroshi and Nakanishi, Yoichi and Okamoto, Isamu},
  title = {Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema},
  journal = {Respirology},
  year = {2026},
  volume = {31},
  number = {11},
  pages = {1117--1125},
  doi = {10.1002/resp.70285}
}
Kostenlos starten →